The Use of CRISPR/Cas9 Technology in Engineering Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy for the Treatment of Cancer in Brazil

被引：0
|
作者：
Carvalho, Julia [1 ]
Cupello, Mauricio [2 ]
Medina, Romulo [2 ]
机构：
[1] INCA, Rio De Janeiro, Brazil
[2] Unigranrio, Rio De Janeiro, Brazil
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
CAR-T; CRISPR/Cas9; Brazil; gene editing; universal CAR-T cells;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT-312
引用
收藏
页码：S525 / S526
页数：2
相关论文
共 50 条
  • [41] HEALTH TECHNOLOGY ASSESSMENT FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES FOR CANCER
    Hollier-Hann, G.
    Brown, A.
    Ralston, S.
    Curry, A.
    Cork, D.
    VALUE IN HEALTH, 2018, 21 : S65 - S65
  • [42] T Cell Receptor Modification by Highly Specific TALEN and CRISPR/Cas9
    Knipping, Friederike
    Petri, Karl
    Ruggiero, Eliana
    Osborn, Mark
    Tolar, Jakub
    Schmidt, Manfred
    von Kalle, Christof
    Gabriel, Richard
    MOLECULAR THERAPY, 2016, 24 : S50 - S50
  • [43] CRISPR Activation Screen to Optimize Chimeric Antigen Receptor (CAR) T Cell Immunophenotype
    Zhu, Wenjun
    Kelly, Conor
    Dagur, Pradeep
    Dunbar, Cynthia E.
    Cordes, Stefan
    BLOOD, 2023, 142
  • [44] Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology
    Khajuria, Ocean
    Sharma, Neha
    Vaishno, Shri Mata
    ADVANCES IN CANCER BIOLOGY-METASTASIS, 2021, 3
  • [45] A Comprehensive Review of Recent Advancements in Cancer Immunotherapy and Generation of CAR T Cell by CRISPR-Cas9
    Al Saber, Md.
    Biswas, Partha
    Dey, Dipta
    Abu Kaium, Md.
    Islam, Md. Aminul
    Tripty, Miss Ismoth Ara
    Rahman, MD. Hasanur
    Rahaman, Tanjim Ishraq
    Biswas, Md. Yeaman
    Paul, Priyanka
    Rahman, Md. Ataur
    Hasan, Md. Nazmul
    Kim, Bonglee
    PROCESSES, 2022, 10 (01)
  • [46] Challenges to Chimeric Antigen Receptor (CAR)-T Cell Therapy for Cancer
    Magee, Michael S.
    Snook, Adam E.
    DISCOVERY MEDICINE, 2014, 18 (100) : 265 - 271
  • [47] GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy
    Caforio, M.
    Iacovelli, S.
    Quintarelli, C.
    Locatelli, F.
    Folgiero, Valentina
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [48] GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy
    M Caforio
    S Iacovelli
    C Quintarelli
    F Locatelli
    Valentina Folgiero
    Journal of Experimental & Clinical Cancer Research, 43
  • [49] Engineering CRISPR/Cas9 therapeutics for cancer precision medicine
    Sharma, Aditya Kumar
    Giri, Anil K.
    FRONTIERS IN GENETICS, 2024, 15
  • [50] CRISPR/Cas9 advances engineering of microbial cell factories
    Jakociunas, Tadas
    Jensen, Michael K.
    Keasling, Jay D.
    METABOLIC ENGINEERING, 2016, 34 : 44 - 59
12345